SANUWAVE Health, Inc. Costs and Expenses
SANUWAVE Health, Inc. (SNWV) reported Costs and Expenses of $590.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-03-26
- SANUWAVE Health, Inc. costs and expenses for fiscal 2025 was $590.00K, a 22.41% increase from fiscal 2024.
- SANUWAVE Health, Inc. costs and expenses for fiscal 2024 was $482.00K, a 0.41% decline from fiscal 2023.
- SANUWAVE Health, Inc. costs and expenses for fiscal 2023 was $484.00K, a 49.38% increase from fiscal 2022.
- SANUWAVE Health, Inc. costs and expenses for fiscal 2022 was $324.00K, a 14.06% decline from fiscal 2021.
| Period end | Costs and Expenses 12 month |
|---|---|
| 2025-12-31 | $590.00K 10-K · filed 2026-03-26 |
| 2024-12-31 | $482.00K 10-K · filed 2026-03-26 |
| 2023-12-31 | $484.00K 10-K · filed 2025-03-20 |
| 2022-12-31 | $324.00K 10-K · filed 2024-03-21 |
| 2021-12-31 | $377.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |